Decentralized clinical trials (DCTs) have gained long-standing interest, yet their adoption as a new paradigm remains uncertain even with broader acceptance from regulatory and industry. This study aims to unveil its evolutional trend, which…
Continue Reading
Groundbreaking Transformation in Clinical Research
Mayo Clinic’s ambitious Clinical Trials Beyond Walls (CTBW) program represents a paradigm shift in medical research, leveraging cutting-edge telehealth technology and remote assessment capabilities to conduct clinical trials in patients’…
Made possible through pilot funding and informed by user experience research, Mayo Clinic’s Clinical Trials Beyond Walls initiative leverages telehealth, remote assessments and other hospital-at-home innovations to bring all or some trial aspects into…
Continue Reading
Meghan Harrington, VP of Clinical Trial Financial Management at Medidata
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating,…
Continue Reading
The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already…
Continue Reading
Andy Molnar, CEO of the Digital Therapeutics Alliance, has been selected as an industry representative for the FDA’s Digital Health Advisory Committee (DHAC). The FDA established the DHAC to ensure safe and effective regulation of…
Continue Reading
The modern landscape of clinical trials is expanding to include hybrid and decentralized approaches to conducting research. As the methods of conducting clinical trials diversify, clinical trial logistics also increase in complexity. In 2024,…
Continue Reading
So, if there is a study activity, that can be decentralized, that can be done virtually, why burdening patients to bring them to the hospital? Build that flexibility into the protocol, it will allow…
Continue Reading
What You Should Know:
– Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round led by Kin, Contrary, and Footwork.
– The strategic funding fuels…
Continue Reading
What You Should Know:
– Curavit Clinical Research, a leader in decentralized clinical trials (DCTs) for digital therapeutics (DTx), successfully completed a study for the Sana Device, a virtual reality (VR) mask aiming to reduce…
Continue Reading
